Security key
45779A846
InspireMD, Inc. - Common Stock, par value $0.0001 per share (NSPR)
CUSIP: 45779A846
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 250,370
- Total 13F value
- $175,284
- Share change
- 0
- SEC-reported price per share
- $0.70
- Number of holders
- 1
- Shares outstanding
- 48,244,715
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
NSPR full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
InspireMD, Inc. SEC filings
InspireMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45779A846
Recent filing periods:
Ownership snapshot
Top reported holders of NSPR - InspireMD, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MARSHALL WACE, LLP
Disclosed value leader
MARSHALL WACE, LLP
Comparable rows
15/15
Latest evidence
27 May 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
13D/G row: MARSHALL WACE, LLP
Showing 1-6 of 15 holder rows.
Quick read
MARSHALL WACE, LLP leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MARSHALL WACE, LLP's linked filing trail.
Comparable ownership
Top 5
MARSHALL WACE, LLP
10%
Nantahala Capital Management, LLC
10%
Rosalind Advisors, Inc.
9.2%
Michael A. Lawless
8.6%
Aberdeen Group plc
7.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MARSHALL WACE, LLP |
13D/G
13F
Company
|
10%
|
$67,729,915
28,103,699 shares
|
$0 | 30 Sep 2025 |
| Nantahala Capital Management, LLC |
13D/G
13F
Company
|
10%
|
$6,458,327
4,819,647 shares
|
+$755,650 | 31 Mar 2026 |
| Rosalind Advisors, Inc. |
13D/G
13F
Company
|
9.2%
|
$19,557,045
10,987,104 shares
|
$0 | 31 Dec 2025 |
| Michael A. Lawless |
13D/G
3/4/5
Chief Financial Officer
|
8.6%
|
$8,711,502
3,614,731 shares
|
$0 | 26 Jun 2025 |
| Aberdeen Group plc |
13D/G
13F
Company
|
7.5%
|
$5,648,588
3,173,364 shares
|
+$1,232,200 | 31 Dec 2025 |
| ORBIMED ADVISORS LLC |
13D/G
13F
Company
|
7.4%
|
$5,577,461
3,133,405 shares
|
+$1,780,000 | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
250,370
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
34
Q2 2026 holders
1
Holder diff
-33
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend